system
ra
play
central
role
regul
cardiovascular
renal
physiolog
contemporari
view
ra
evolv
simpl
linear
pathway
involv
convers
angiotensinogen
angiotensin
ii
ang
ii
via
process
facilit
renin
angiotensin
convert
enzym
ace
much
complex
system
involv
homologu
ace
multipl
angiotensin
peptid
play
supplementari
role
figur
ra
mani
year
thought
endocrin
system
enzym
peptid
releas
system
circul
act
target
organ
recent
recognis
organ
includ
brain
kidney
heart
liver
pancrea
reproduct
organ
skin
gastrointestin
tract
constitut
express
compon
requir
allow
autonom
function
local
ra
perform
paracrin
autocrin
function
tabl
summaris
current
view
ra
key
compon
physiolog
clinic
effect
essenti
rel
activ
two
counterbalanc
pathway
determin
predomin
tissu
effect
proinflammatori
profibrot
pathway
includ
classic
ra
compon
ace
ang
ii
renin
prorenin
chymas
neutral
endopeptidas
nep
also
known
neprilysin
renin
glycoprotein
deriv
predominantli
juxtaglomerular
apparatu
kidney
aspartyl
proteas
cleav
angiotensinogen
angiotensin
renin
proenzym
prorenin
previous
consid
physiolog
demonstr
independ
effect
via
signal
pro
renin
receptor
prr
classic
ra
compris
zinc
metalloproteinas
ace
ang
ii
induc
vasoconstrict
salt
water
retent
thirst
respons
cardiac
hypertrophi
tissu
inflamm
fibrosi
coupl
domain
receptor
angiotensin
type
receptor
ang
ii
also
stimul
adren
gland
secret
aldosteron
result
renal
sodium
water
retent
inhibit
pathway
either
ace
inhibitor
antagonist
benefici
effect
hypertens
cardiac
failur
ischaem
heart
diseas
diabet
nephropathi
renal
fibrosi
chymas
express
heart
vascular
wall
secret
activ
mast
cell
act
altern
enzym
ace
gener
ang
ii
ang
nep
membran
bound
zinc
metalloproteinas
structur
distinct
ace
discov
key
enzym
involv
cleavag
recent
year
shown
also
role
format
ang
ang
inactiv
atrial
natriuret
degrad
amyloid
protein
involv
pathogenesi
alzheim
diseas
net
effect
nep
inhibit
vasodilat
natriuresi
properti
encompass
vasopeptidas
inhibitor
target
ace
nep
may
addit
effect
ace
contrast
altern
ra
compris
ang
act
via
coupl
receptor
ma
vasodilatori
antihypertens
cardioprotect
effect
varieti
zinc
metalloproteinas
homologu
ace
cleav
singl
amino
acid
ang
ii
form
heptapeptid
ang
inde
part
clinic
benefit
attribut
ace
inhibitor
blocker
arb
may
divers
classic
ra
compon
toward
ang
subsequ
ma
receptor
complex
ra
highlight
recent
find
regard
action
angiotensin
peptid
includ
angiotensin
iii
ang
iii
also
denot
ang
angiotensin
iv
ang
iv
also
known
ang
receptor
ang
iii
form
cleavag
ang
ii
aminopeptidas
ang
iv
result
convers
aminopeptidas
b
n
figur
receptor
affin
ang
ii
ang
iii
ang
iv
ang
also
thought
effect
counteract
analog
ma
receptor
vasodilatori
downstream
action
previous
recognis
larg
import
role
foetal
develop
recent
shown
upregul
atherosclerot
cutan
pancreat
stimul
neurit
outgrowth
marker
neuron
ang
iii
believ
action
analog
ang
ii
ang
iv
appear
oppos
effect
ang
ii
act
predominantli
via
formerli
known
insulin
regul
aminopeptidas
irap
greatest
role
ang
iv
central
nervou
system
cn
posit
effect
neuron
develop
learn
consider
evid
compon
ra
present
varieti
organ
support
theori
local
express
modul
ra
play
import
role
tissu
homeostasi
role
may
summaris
involv
fluid
electrolyt
transport
region
blood
flow
regul
promot
wound
heal
respons
includ
cell
prolifer
inflamm
fibrosi
region
effect
ra
list
kidney
local
angiotensinogen
convert
renin
ang
turn
cleav
tubular
brush
border
ace
ang
ii
facilit
sodium
fluid
absorpt
via
lumin
may
influenc
blood
pressur
independ
system
ang
ii
level
vascular
heart
express
renin
prr
ace
chymas
angiotensinogen
compon
modul
myocyt
prolifer
cardiac
brain
shown
express
renin
angiotensinogen
ang
ii
ang
iii
ang
iv
ang
compon
regul
blood
pressur
fluid
electrolyt
balanc
thirst
mainten
barrier
neuron
develop
includ
learn
memori
liver
express
renin
angiotensinogen
ang
ii
ace
ang
ma
receptor
upregul
diseas
furthermor
arb
ang
demonstr
reduc
liver
fibrosi
anim
pancrea
ang
ii
shown
inhibit
glucos
stimul
insulin
secret
via
regul
exocrin
enzym
secret
local
ra
identifi
shown
involv
tissu
homeostasi
reproduct
organ
skin
even
adipos
detail
review
local
ra
effect
publish
attent
paid
small
intestin
figur
outlin
ace
neutral
endopeptidas
ace
shown
human
locat
abund
brush
border
epitheli
cell
mesenter
microvascular
mrna
protein
present
larg
amount
small
intestin
epitheli
brush
border
musculari
mucosa
musculari
propria
well
microvascular
endothelium
vascular
smooth
muscl
remark
highest
tissu
concentr
human
bodi
ace
mrna
found
termin
ileum
duodenum
express
nep
demonstr
rat
intestin
wall
suppress
administr
combin
acenep
inhibitor
angiotensin
receptor
localis
epitheli
brush
circular
longitudin
muscl
layer
myenter
plexu
also
strongli
express
appear
larg
restrict
myenter
small
vessel
musculari
propria
also
express
earli
studi
rat
intestin
ang
ii
bind
site
report
confin
subsequ
report
identifi
express
lesser
amount
musculari
mucosa
mucosa
includ
epitheli
renin
mrna
renin
detect
human
small
angiotensin
peptid
ang
ii
detect
crypt
junction
epitheli
date
express
angiotensinogen
ang
ang
human
small
intestin
report
howev
angiotensinogen
wide
localis
rat
brush
border
epitheli
cell
lamina
propria
musculari
mucosa
submucos
blood
vessel
musculari
angiotensinogen
mrna
isol
concentr
liver
rat
high
level
precursor
ang
locat
rat
thu
requir
compon
local
product
action
ang
ii
appear
present
small
intestin
evid
import
role
ra
varieti
intestin
process
bicarbon
secret
stimul
ang
ii
via
sodium
water
absorpt
jejunum
ileum
process
appear
modul
ang
ii
conjunct
enter
sympathet
nervou
appli
low
dose
rat
jejunum
ang
ii
stimul
sodium
water
absorpt
high
dose
unexpectedli
inhibit
absorpt
ang
ii
ang
iii
may
also
increas
sodium
water
absorpt
via
stimul
releas
noradrenalin
sympathet
neuron
turn
may
act
adrenerg
receptor
basal
surfac
epitheli
glucos
absorpt
ang
ii
also
shown
inhibit
rat
jejun
glucos
transport
glucos
uptak
digest
absorpt
peptid
brush
border
ace
thought
function
peptidas
allow
mucos
digest
absorpt
increas
activ
neutral
amino
acid
transport
mutat
rare
amino
acid
defici
disord
hartnup
disord
clinic
manifest
cerebellar
ataxia
skin
secret
role
activ
secret
suggest
observ
target
coronaviru
mediat
sever
acut
respiratori
syndrom
patient
infect
suffer
wateri
diarrhoea
exact
mechan
remain
limit
studi
ra
compon
colon
wall
figur
combin
immunohistochemistri
renin
found
surfac
epithelium
lamina
propria
mesenchym
cell
microvascular
wall
musculari
mucosa
detect
surfac
epitheli
cell
crypt
base
lamina
propria
macrophag
myofibroblast
mucos
vessel
wall
weak
express
found
surfac
epithelium
crypt
mesenchym
ace
also
weakli
express
part
surfac
epithelium
promin
mesenter
microvascular
wall
lamina
propria
submucos
mesenchym
appear
localis
mesenter
microvascular
endothelium
colon
present
angiotensinogen
mrna
also
isol
homogenis
rat
express
examin
human
colon
limit
rang
function
role
attribut
compon
ra
colon
small
intestin
ang
ii
shown
increas
sodium
water
reabsorpt
rat
nacl
coupl
respons
circular
longitudin
muscl
contract
ang
ii
also
suggest
role
normal
colon
detail
ra
may
also
involv
inflamm
associ
ibd
mucos
level
ang
ang
ii
higher
patient
activ
crohn
coliti
compar
normal
control
patient
ulcer
compon
ra
present
mucos
biopsi
specimen
gastric
antrum
bodi
healthi
adult
figur
renin
angiotensinogen
seen
lamina
propria
mesenchym
cell
vascular
endotheli
cell
observ
gastric
epithelium
mainli
basal
surfac
lamina
propria
mesenchym
cell
vascular
endothelium
note
subgroup
endocrin
cell
base
antral
mucos
gland
ace
nep
vascular
endotheli
cell
part
mucosa
investig
howev
note
ace
fundic
chief
cell
mucin
secret
cell
longitudin
circular
muscl
stomach
demonstr
respond
vitro
ang
ii
suggest
presenc
appropri
receptor
gastric
date
function
pathogen
role
attribut
ra
stomach
role
local
ra
gastric
inflamm
suggest
higher
express
express
helicobact
pylori
posit
h
pylori
neg
potenti
ulcer
anim
model
ang
immunoreact
ace
found
lamina
propria
microvascular
wall
identifi
superfici
stratifi
circular
longitudin
muscl
figur
ang
ii
caus
contract
isol
oesophag
smooth
muscl
vitro
antagonist
candesartan
inhibit
peristalt
contract
distal
express
ra
compon
report
two
compon
ra
studi
first
ace
subject
intens
interest
role
sarcoidosi
granulomat
condit
studi
serum
ace
concentr
yield
larg
conflict
find
ibd
mani
studi
show
reduc
find
mani
studi
limit
rel
small
number
patient
serum
ace
level
associ
ace
gene
insertiondelet
id
polymorph
higher
level
seen
dd
polymorph
id
matsuda
et
al
show
ace
gene
polymorph
variat
similar
patient
cd
patient
uc
control
serum
ace
level
lower
patient
ibd
adjust
furthermor
demonstr
ace
level
significantli
increas
nine
patient
activ
cd
achiev
clinic
remiss
larger
studi
involv
uc
patient
cd
patient
also
found
differ
ace
gene
polymorph
compar
normal
control
subgroup
analysi
reveal
higher
proport
dd
genotyp
uc
patient
manifest
odd
ratio
inde
difficult
reconcil
find
unifi
hypothesi
regard
role
ace
ibd
pathogenesi
possibl
inflammatori
cytokin
downregul
system
endotheli
ace
wherea
ang
ii
produc
via
local
intestin
ace
contribut
tissu
inflamm
tissu
ace
level
measur
activ
ibd
major
area
investig
focuss
angiotensin
peptid
level
cd
genotyp
analys
reveal
signific
associ
aa
genotyp
cohort
patient
ibd
genotyp
result
increas
product
angiotensinogen
via
substitut
gene
inde
mucos
level
ang
ang
ii
elev
rectosigmoid
biopsi
patient
crohn
coliti
compar
patient
uc
normal
signific
correl
note
level
endoscop
grade
coliti
although
find
demonstr
compon
local
tissu
ra
probabl
play
part
inflamm
prove
causal
link
pathogenesi
ibd
nonetheless
suggest
inhibit
local
ra
provid
potenti
avenu
target
inflamm
fibrosi
angiotensin
convert
enzym
inhibit
angiotensin
receptor
antagon
shown
produc
number
benefici
effect
rodent
model
intestin
inflamm
ang
ii
receptor
express
upregul
dextran
sodium
sulphat
dss
coliti
wide
studi
mous
model
coliti
inflamm
significantli
amelior
ace
inhibitor
enalaprilat
given
parenter
reduc
inflamm
topic
enalaprilat
reduc
express
fibrosi
mice
administr
arb
valsartan
significantli
reduc
macroscop
inflamm
mice
trinitrobenzen
sulphon
acid
tnb
induc
coliti
reduc
microscop
inflamm
rais
cytokin
secret
regulatori
cell
ace
inhibitor
captopril
reduc
macroscop
microscop
inflamm
fibrosi
mrna
express
mice
homozyg
defici
angiotensinogen
protect
coliti
reduc
greater
product
anim
studi
restrict
classic
ra
pathway
nep
knockout
mice
shown
sever
coliti
respons
dinitrobenzen
sulphon
acid
mice
prevent
administr
recombin
evid
suggest
ra
dysfunct
may
potenti
diseas
ibd
provid
target
therapi
come
recent
studi
involv
model
multipl
sclerosi
ms
helper
type
type
cell
strongli
implic
pathogenesi
ibd
especi
cd
lisinopril
candesartan
demonstr
suppress
cytokin
express
induc
regulatori
cell
experiment
autoimmun
enceph
eae
mous
model
group
shown
crucial
role
ang
ii
murin
autoimmun
possibl
involv
perturb
ra
compon
solid
organ
malign
repres
fascin
expans
insight
local
tissu
ra
earli
epidemiolog
studi
demonstr
reduc
risk
incid
fatal
cancer
patient
ace
inhibitor
versu
contrast
recent
report
higher
risk
lung
cancer
patient
take
howev
two
larg
sinc
report
increas
studi
limit
retrospect
design
increas
vitro
data
suggest
protect
effect
inhibit
cancer
cell
prolifer
invas
metastasi
varieti
solid
gastric
cancer
ang
ii
express
greater
extent
adjac
normal
ace
gene
polymorph
allel
increas
risk
nodal
metastasi
tumour
stage
patient
gastric
gastric
cancer
cell
cultur
ang
ii
stimul
map
kinas
survivin
activ
increas
like
mechan
ra
may
influenc
cancer
biolog
increas
via
increas
express
vascular
endotheli
growth
factor
vefg
mous
model
ace
inhibit
arb
reduc
colorect
cancer
liver
metastas
prolong
surviv
periton
inde
ace
inhibitor
use
independ
protect
distal
metastasi
singl
centr
retrospect
review
patient
colorect
also
patient
treat
ace
inhibitor
trend
toward
reduct
risk
oesophag
adenocarcinoma
retrospect
studi
uk
gener
practic
research
recent
intrigu
insight
involv
ra
syndrom
pj
shorn
colleagu
shown
mice
gene
delet
associ
pj
result
mark
transcript
upregul
renin
gene
also
increas
ace
express
ang
ii
human
pj
tumour
tissu
note
increas
stromal
tissu
reduc
function
role
ra
smooth
muscl
contract
suggest
might
target
motil
dysfunct
exampl
abil
ang
ii
blockad
inhibit
contract
oesophag
bodi
lower
oesophag
sphincter
le
smooth
muscl
togeth
demonstr
reduct
amplitud
contract
primari
peristalt
oesophag
wave
le
manometri
suggest
possibl
role
treatment
hypercontractil
oesophag
disord
diffus
oesophag
spasm
nutcrack
oesophagu
achalasia
furthermor
select
contract
le
may
option
treatment
reflux
diseas
condit
affect
contribut
small
larg
intestin
muscl
contractil
also
provid
opportun
interven
function
intestin
motil
disord
agon
blockad
furthermor
role
ace
intestin
fluid
electrolyt
absorpt
suggest
potenti
mechan
modul
fluid
shift
across
brush
border
subsequ
effect
stool
consist
frequenc
ra
play
import
role
regul
smooth
muscl
tone
mesenter
vasculatur
acut
hypovolaemia
system
sepsi
splanchnic
vasoconstrict
occur
homeostat
respons
preserv
cerebr
renal
blood
flow
predispos
gut
ischaemia
splanchnic
respons
shown
correl
markedli
increas
express
ang
furthermor
neg
pressur
induct
normal
human
volunt
also
shown
rais
serum
ang
ii
reduc
intestin
mucos
nitric
oxid
administr
candesartan
maintain
jejun
mucos
perfus
sever
hypovolaemia
pig
reduc
porcin
studi
report
improv
mucos
oxygen
deliveri
improv
intestin
mucos
acidosi
pig
administ
candesartan
endotox
result
replic
tardo
et
al
pig
burn
endotoxin
induc
gut
ischaemia
model
intestin
permeabl
bacteri
transloc
reduc
administr
ang
ii
inhibitor
obviou
limit
factor
appli
ang
ii
blockad
human
risk
mesenter
ischaemia
potenti
current
arb
ace
inhibitor
caus
hypotens
kidney
injuri
although
advers
renal
consequ
note
one
porcin
ubiquit
system
wide
array
homeostat
role
investig
therapi
manipul
ra
extens
apart
role
receptor
blockad
ace
inhibit
treatment
hypertens
cardiovascular
kidney
diseas
new
drug
target
ma
receptor
receptor
renin
nep
well
recombin
ang
trial
variou
applic
tabl
limit
knowledg
effect
current
avail
ace
inhibitor
arb
gastrointestin
function
dose
employ
cardiovascular
renal
effect
molecular
level
drug
may
result
advers
effect
includ
nausea
diarrhoea
constip
idiosyncrat
manner
per
cent
patient
often
note
similar
number
patient
placebo
arm
randomis
control
trial
like
gastrointestin
tissu
concentr
achiev
medic
current
dose
insuffici
note
clinic
effect
furthermor
effect
drug
patholog
state
like
function
gut
disord
ibd
describ
applic
human
gastrointestin
diseas
drug
manipul
ra
need
target
relev
area
gut
obtain
satisfactori
tissu
effect
without
system
advers
reaction
ideal
compris
deliveri
mucosa
absorpt
bind
cellular
receptor
suffici
first
pass
hepat
convers
inact
metabolit
limit
system
effect
signific
bodi
literatur
demonstr
exist
pathophysiolog
relev
local
tissu
system
given
current
evid
involv
ra
gastrointestin
fluid
electrolyt
homeostasi
smooth
muscl
control
inflamm
malign
follow
manipul
system
could
benefit
rang
gi
patholog
therapi
target
gastrointestin
ra
attract
given
excel
safeti
toler
profil
confirm
benefit
organ
diseas
hope
recent
emerg
experiment
evid
support
role
local
ra
intestin
disord
provid
greater
impetu
initi
clinic
trial
human
diseas
